“Orthobiologics” Have Promise Across Surgery Categories

Terry Stanton

The use of biologic agents such as platelet-rich plasma (PRP) and recombinant human bone morphogenetic protein (rhBMP) continues to draw heightened interest. Research is expanding the understanding of both their potential and their limitations. In addition, results of clinical experience are helping to guide physicians in applying these products in their practices.

During the session “PRP, BMP, and Stem Cells: What Surgeons Need to Know,” a panel of surgeons reviewed the current state of knowledge for these “orthobiologics” and offered guidance on their indications in treatment settings such as the spine, rotator cuff and tendons, trauma, and osteoporosis and fracture.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!